A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen α₂(I) and Other Promoters

REFERENCES

• Accolla, R. S., M. Jotterand-Bellomo, L. Scarpellino, A. Maffei, G. Carra, and J. Guardiola. 1986. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. Exp. Med. 164:369–374.
   PubMed Web of Science ®Google Scholar
• Asao, H., and X. Y. Fu. 2000. Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation. J. Biol. Chem. 275:867–874.
   PubMed Web of Science ®Google Scholar
• Beresford, G. W., and J. M. Boss. 2001. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2:652–657.
   PubMed Web of Science ®Google Scholar
• Berger, S. L., W. D. Cress, A. Cress, S. J. Triezenberg, and L. Guarent. 1990. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors. Cell 64:1199–1208.
   Google Scholar
• Bi, W., L. Wu, F. Coustry, B. de Crombrugghe, and S. N. Maity. 1997. DNA binding specificity of the CCAAT-binding factor CBF/NF-Y. J. Biol. Chem. 272:26562–26572.
   PubMedGoogle Scholar
• Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749–795.
   PubMed Web of Science ®Google Scholar
• Boshart, M., M. Kluppel, A. Schmidt, G. Schutz, and B. Luckow. 1992. Reporter constructs with low background activity utilizing the cat gene. Gene 110:129–130.
   PubMedGoogle Scholar
• Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167–178.
   PubMed Web of Science ®Google Scholar
• Chang, C. H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367–1374.
   PubMedGoogle Scholar
• Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, M. J. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective MHC-II and Ii gene induction. Immunity 1:687–697.
   PubMedGoogle Scholar
• Chin, K.-C., G. X. Li, and J. P.-Y. Ting. 1997. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA 94:2501–2506.
   PubMedGoogle Scholar
• Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719–722.
   PubMed Web of Science ®Google Scholar
• Chrivia, J. C., R. P. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855–859.
   PubMed Web of Science ®Google Scholar
• Coustry, F., S. N. Maity, and B. de Crombrugghe. 1995. Studies on transcription activation by the multimeric CCAAT-binding factor CBF. J. Biol. Chem. 270:468–475.
   PubMedGoogle Scholar
• Dickensheets, H. L., and R. P. Donnelly. 1999. Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J. Leukoc. Biol. 65:307–312.
   PubMedGoogle Scholar
• Dodge, G. R., A. Diaz, C. Sanz-Rodriguez, A. M. Reginato, and S. A. Jimenez. 1998. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes. Arthritis Rheum. 41:274–283.
   PubMedGoogle Scholar
• Donnelly, R. P., S. L. Freeman, and M. P. Hayes. 1995. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. J. Immunol. 155:1420–1427.
   PubMed Web of Science ®Google Scholar
• Dorn, A., J. Bollekens, A. Staub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT box-binding proteins. Cell 50:863–872.
   PubMed Web of Science ®Google Scholar
• Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869–884.
   PubMed Web of Science ®Google Scholar
• Fontes, J. D., S. Kanazawa, D. Jean, and B. M. Peterlin. 1999. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell. Biol. 19:941–947.
   PubMedGoogle Scholar
• Gill, G., and M. Ptashne. 1988. Negative effect of the transcriptional activator GAL4. Nature 334:721–724.
   PubMed Web of Science ®Google Scholar
• Goldring, M. B., L. J. Sandell, M. L. Stephenson, and S. M. Krane. 1986. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J. Biol. Chem. 264:9049–9055.
   Google Scholar
• Gourley, T., S. Roys, N. W. Lukacs, S. L. Kunkel, R. A. Flavell, and C. H. Chang. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10:377–386.
   PubMedGoogle Scholar
• Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Baldwin Jr.. 1999. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785–5799.
   PubMed Web of Science ®Google Scholar
• Hake, S. B., K. Masternak, C. Kammerbauer, C. Janzen, W. Reith, and V. Steimle. 2000. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation. Mol. Cell. Biol. 20:7716–7725.
   PubMedGoogle Scholar
• Higashi, K., D. J. Kouba, Y. J. Song, J. Uitto, and A. Mauviel. 1998. A proximal element within the human alpha 2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-alpha response element, mediates transcriptional repression by interferon-gamma. Matrix Biol. 16:447–456.
   PubMedGoogle Scholar
• Jaffe, H. A., Z. Gao, Y. Mori, L. Li, and J. Varga. 1999. Selective inhibition of collagen gene expression in fibroblasts by an interferon-gamma transgene. Exp. Lung Res. 25:199–215.
   PubMedGoogle Scholar
• Jimenez, S. A., B. Freundlich, and J. Rosenbloom. 1984. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J. Clin. Investig. 74:1112–1116.
   PubMed Web of Science ®Google Scholar
• Kahari, V. M., Y. Q. Chen, M. W. Su, F. Ramirezand, and J. Uitto. 1990. Tumor necrosis factor-alpha and interferon-gamma suppress the activation of human type I collagen gene expression by transforming growth factor-beta 1. Evidence for two distinct mechanisms of inhibition at the transcriptional and posttranscriptional levels. J. Clin. Investig. 86:1489–1495.
   PubMed Web of Science ®Google Scholar
• Kretsovali, A.. 1998. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:6777–6783.
   PubMed Web of Science ®Google Scholar
• Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223–226.
   PubMed Web of Science ®Google Scholar
• Li-Weber, M., I. V. Davydov, H. Krafft, and P. H. Krammer. 1994. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153:4122–4133.
   PubMedGoogle Scholar
• Link, H.. 1998. The cytokine storm in multiple sclerosis. Mult. Scler. 4:12–15.
   PubMed Web of Science ®Google Scholar
• Liu, X., and A. J. Berk. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol. Cell. Biol. 15:6474–6478.
   PubMedGoogle Scholar
• Maity, S. N., P. T. Golumbek, G. Karsenty, and B. de Crombrugghe. 1988. Selective activation of transcription by a novel CCAAT binding factor. Science 241:582–585.
   PubMedGoogle Scholar
• Maity, S. N., and B. de Crombrugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem. Sci. 23:174–178.
   PubMedGoogle Scholar
• Mao, C., D. Davies, I. M. Kerr, and G. R. Stark. 1993. Mutant human cells defective in induction of major histocompatibility complex class II genes by interferon gamma. Proc. Natl. Acad. Sci. USA 90:2880–2884.
   PubMedGoogle Scholar
• Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:1156–1166.
   PubMed Web of Science ®Google Scholar
• Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 8:157–166.
   PubMed Web of Science ®Google Scholar
• Nekrep, N., N. Jabrane-Ferrat, and B. M. Peterlin. 2000. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex. Mol. Cell. Biol. 20:4455–4464.
   PubMedGoogle Scholar
• Penton Ogryzko, V. V., R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
   PubMedGoogle Scholar
• Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 160:233–240.
   PubMedGoogle Scholar
• Piskurich, J. F., M. W. Linhoff, Y. Wang, and J. P.-Y. Ting. 1999. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1: interferon regulatory factor 1, and transforming growth factor beta. Mol. Cell. Biol. 19:431–440.
   PubMedGoogle Scholar
• Ptashne, M., and A. A. Gann. 1990. Activators and targets. Nature 346:329–331.
   PubMed Web of Science ®Google Scholar
• Ramana, C. V., N. Grammatikakis, M. Chernov, H. Nguyen, K. C. Goh, B. R. Williams, and G. R. Stark. 2000. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J. 19:263–272.
   PubMedGoogle Scholar
• Rosenbloom, J., G. Feldman, B. Freundlich, and S. A. Jimenez. 1984. Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem. Biophys. Res. Commun. 123:365–372.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
   Google Scholar
• Schmidt, A., P. Rossi, and B. de Crombrugghe. 1986. Transcriptional control of the mouse alpha 2(I) collagen gene: functional deletion analysis of the promoter and evidence for cell-specific expression. Mol. Cell. Biol. 6:347–354.
   PubMed Web of Science ®Google Scholar
• Sefton, B. M.. 1999. Analysis of protein phosphorylation. Current protocols in molecular biology.. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 18.2.1–18.2.8. John Wiley & Sons, Inc., New York, N.Y
   Google Scholar
• Sharma, B., and R. V. Iozzo. 1998. Transcriptional silencing of perlecan gene expression by interferon-gamma. J. Biol. Chem. 273:4642–4646.
   PubMed Web of Science ®Google Scholar
• Sibinga, N. E., H. Wang, M. A. Perrella, W. O. Endege, C. Patterson, M. Yoshizumi, E. Haber, and M. E. Lee. 1999. Interferon-gamma-mediated inhibition of cyclin A gene transcription is independent of individual cis-acting elements in the cyclin A promoter. J. Biol. Chem. 274:12139–12146.
   PubMed Web of Science ®Google Scholar
• Sisk, T. J., T. Gourley, S. Roys, and C. H. Chang. 2000. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J. Immunol. 165:2511–2517.
   PubMed Web of Science ®Google Scholar
• Sobulo, O. M., J. Borrow, R. Tomek, S. Reshmi, A. Harden, B. Schlegelberger, D. Housman, N. A. Doggett, J. D. Rowley, and N. J. Zeleznik-Le. 1997. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc. Natl. Acad. Sci. USA 94:8732–8737.
   PubMed Web of Science ®Google Scholar
• Springer, T. A.. 1999. Analysis of protein. Current protocols in molecular biology.. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 10.16.1–10.16.11. John Wiley & Sons, Inc., New York, N.Y
   Google Scholar
• Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135–146.
   PubMed Web of Science ®Google Scholar
• Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106–109.
   PubMed Web of Science ®Google Scholar
• Struhl, K.. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599–606.
   PubMed Web of Science ®Google Scholar
• Varga, J., A. Olsen, J. Herhal, G. Constantine, J. Rosenbloom, and S. A. Jimenez. 1990. Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur. J. Clin. Investig. 20:487–493.
   PubMed Web of Science ®Google Scholar
• Wade, P. A., and A. P. Wolffe. 1997. Histone acetyltransferases in gene control. Curr. Biol. 7:R82–R84.
   PubMedGoogle Scholar
• Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. P. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA-binding transcription factors. EMBO J. 13:4042–4053.
   PubMedGoogle Scholar
• Wright, K. L., K. C. Chin, M. W. Linhoff, C. Skinner, J. A. Brown, J. M. Boss, G. Stark, and J. P. Ting. 1998. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoter in vivo. Proc. Natl. Acad. Sci. USA 95:6267–6272.
   PubMedGoogle Scholar
• Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382:319–324.
   PubMed Web of Science ®Google Scholar
• Yarden, A., and A. Kimchi. 1986. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science 234:1419–1421.
   PubMed Web of Science ®Google Scholar
• Yuan, W., T. Yufit, L. Li, Y. Mori, S. J. Chen, and J. Varga. 1999. Negative modulation of alpha1(I) procollagen gene expression in human skin fibroblasts: transcriptional inhibition by interferon-gamma. J. Cell Physiol. 179:97–108.
   PubMedGoogle Scholar
• Zhu, X. Z., M. W. Linhoff, G. Li, K. Chin, and J. P. Ting. 2000. Transcriptional scaffold: CIITA interacts with NF-Y, RFX and CREB to cause stereospecific regulation of the MHC-II promoter. Mol. Cell. Biol. 20:6051–6064.
   PubMed Web of Science ®Google Scholar